CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation

Max J. Gordon, Paul Tardi, Marc M. Loriaux, Stephen E. Spurgeon, Elie Traer, Tibor Kovacsovics, Lawrence D. Mayer, Jeffrey W. Tyner

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation'. Together they form a unique fingerprint.

Medicine & Life Sciences